Treatment of Cushing Disease With Pituitary-Targeting Seliciclib
Author(s) -
Ning-Ai Liu,
Anat Ben-Shlomo,
John D. Carmichael,
Christina Wang,
Ronald S. Swerdloff,
Anthony P. Heaney,
Garni Barkhoudarian,
Daniel F. Kelly,
Mazen Noureddin,
Lin Lü,
Manish Desai,
Yana Stolyarov,
Kevin C.J. Yuen,
Adam N. Mamelak,
James Mirocha,
Mourad Tighiouart,
Шломо Мелмед
Publication year - 2022
Publication title -
the journal of clinical endocrinology and metabolism
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.206
H-Index - 353
eISSN - 1945-7197
pISSN - 0021-972X
DOI - 10.1210/clinem/dgac588
Subject(s) - medicine , cushing's disease , corticotropic cell , clinical endpoint , gastroenterology , discontinuation , endocrinology , pituitary gland , clinical trial , hormone , disease
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom